Growth Metrics

Alvotech (ALVO) Current Deferred Revenue (2020 - 2025)

Alvotech filings provide 6 years of Current Deferred Revenue readings, the most recent being $30.4 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 90.01% to $30.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $30.4 million, a 90.01% increase, with the full-year FY2025 number at $30.4 million, up 90.01% from a year prior.
  • Current Deferred Revenue hit $30.4 million in Q4 2025 for Alvotech, down from $80.7 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $90.1 million in Q2 2024 to a low of $16.0 million in Q4 2024.
  • Median Current Deferred Revenue over the past 5 years was $59.7 million (2023), compared with a mean of $61.4 million.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 78.19% in 2024 and later surged 90.01% in 2025.
  • Alvotech's Current Deferred Revenue stood at $44.8 million in 2021, then rose by 27.15% to $57.0 million in 2022, then rose by 28.49% to $73.3 million in 2023, then plummeted by 78.19% to $16.0 million in 2024, then surged by 90.01% to $30.4 million in 2025.
  • The last three reported values for Current Deferred Revenue were $30.4 million (Q4 2025), $80.7 million (Q3 2025), and $60.3 million (Q2 2025) per Business Quant data.